Centre for Cellular and Molecular Biology (CCMB), Hyderabad has partnered with a Bengaluru-based company, Eyestem Research Private Limited, to take up research activities on COVID-19.
Highlights: ♦ The collaboration aims to grow novel coronavirus in human cell lines, which will enable in vitro testing of potential drugs and vaccines against the COVID-19.
♦ Eyestem's human lung epithelial cell culture system will be used as part of its Anti-COVID Screening (ACS) platform to understand the molecular and pathological characteristics of the novel coronavirus. ♦ The research will overcome the issues faced to culture the virus outside the human host.
♦ CSIR-CCMB is known for its cutting-edge research work on cellular and molecular biology.
Eyestem Research Private Limited is a cell therapy start-up incubated at the Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru.
♦ C-CAMP is an initiative of the Department of Biotechnology, Ministry of Science and Technology.
♦ Eyestem is working to democratize access to cell therapy and disease modeling platforms and bring their benefit to a large section of humanity.